LEP and metabolic disease: This study offers another novel example in which changes in the gut microbiota lead to leptin activation and thereby induce browning remodelling in WAT and indicates that PNS can potentially be used as modulators of the gut microbiota to induce adipose remodelling via leptin activation and thereby combat obesity and related metabolic disorder.